 |
|
Updated risk assessments for sudden cardiac death in hypertrophic cardiomyopathy patients with implantable cardioverter-defibrillator
Yae Min Park
Korean J Intern Med. 2023;38(1):7-15. Published online 2022 Nov 10 DOI: https://doi.org/10.3904/kjim.2022.144
|
|
Citations to this article as recorded by
 Integrative Approaches in the Management of Hypertrophic Cardiomyopathy: A Comprehensive Review of Current Therapeutic Modalities
Marco Maria Dicorato, Gaetano Citarelli, Francesco Mangini, Rossella Alemanni, Miriam Albanese, Sebastiano Cicco, Cosimo Angelo Greco, Cinzia Forleo, Paolo Basile, Maria Cristina Carella, Marco Matteo Ciccone, Andrea Igoren Guaricci, Ilaria Dentamaro
Biomedicines.2025; 13(5): 1256. CrossRef Optimization of guideline-directed medical treatment for heart failure patients with reduced ejection fraction
Minjung Bak, Jin-Oh Choi
The Korean Journal of Internal Medicine.2023; 38(5): 595. CrossRef Current perspectives of sudden cardiac death management in hypertrophic cardiomyopathy
Lutong Pu, Jialin Li, Weitang Qi, Jinquan Zhang, Hongyu Chen, Zihuan Tang, Yuchi Han, Jie Wang, Yucheng Chen
Heart Failure Reviews.2023; 29(2): 395. CrossRef
|